Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04072198
Title Nivolumab Plus FOLFOXIRI/Bevacizumab in First Line Chemotherapy of Advanced Colorectal Cancer RASm/BRAFm Patients (NIVACOR)
Acronym NIVACOR
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Gruppo Oncologico Italiano di Ricerca Clinica
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Istituto Ospedaliero Fondazione Poliambulanza RECRUITING Brescia Italy Details
Arnas Garibaldi RECRUITING Catania Italy Details
Azienda Ospedaliero-Universitaria Careggi RECRUITING Firenze Italy Details
Istituto Nazionale Tumori Fondazione G.Pascale RECRUITING Napoli Italy Details
Istituto Oncologico Veneto RECRUITING Padova Italy Details
AUSL/IRCCS di Reggio Emilia RECRUITING Reggio Emilia Italy Details
Policlinico Universitario Campus Bio-Medico RECRUITING Roma Italy Details
IRCCS - Casa Sollievo della Sofferenza RECRUITING San Giovanni Rotondo Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field